View Older Stories View More Recent Stories

Feb 25, 2025 10:16PM ROSEN, A LEADING NATIONAL FIRM, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK

Feb 24, 2025 10:11PM ROSEN, A LEADING LAW FIRM, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK

Feb 24, 2025 04:44PM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK

Feb 24, 2025 04:00PM GSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Feb 23, 2025 10:06PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK

Feb 22, 2025 09:53PM ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK

Feb 22, 2025 10:08AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK

Feb 21, 2025 09:32PM ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK

Feb 21, 2025 10:03AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK

Feb 20, 2025 09:27PM ROSEN, A LONGSTANDING LAW FIRM, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK

Feb 19, 2025 09:22PM ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK

Feb 18, 2025 09:22PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK

Feb 18, 2025 06:49PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK

Feb 18, 2025 04:00PM GSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Feb 17, 2025 09:22PM ROSEN, LEADING INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK

Feb 17, 2025 12:34PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK

Feb 16, 2025 09:22PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK

Feb 15, 2025 09:21PM ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK

Feb 14, 2025 09:21PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK

Feb 14, 2025 09:42AM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK

Feb 13, 2025 09:21PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK

Feb 12, 2025 04:00PM GSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Feb 12, 2025 03:20PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK

Feb 12, 2025 05:45AM Morgan Stanley Starts GlaxoSmithKline (GSK:LN) (GSK) at Underweight

Feb 11, 2025 03:15PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK

Feb 10, 2025 06:57PM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK

Feb 8, 2025 10:51PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK

Feb 8, 2025 08:32AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK

Feb 6, 2025 04:00PM GSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Feb 6, 2025 12:38PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK

Feb 5, 2025 01:27PM GlaxoSmithKline (GSK) PT Lowered to $40 at CFRA

Feb 5, 2025 05:38AM GlaxoSmithKline (GSK) Misses Q4 EPS by 26c

Jan 13, 2025 06:09AM GSK (GSK) to Acquire IDRx

Jan 7, 2025 01:15PM GSK (GSK) call put ratio 3.3 calls to 1 put with a focus on January 10 weekly 34 calls.

Jan 7, 2025 11:00AM TD Cowen on Pharma: '10 Events in 2025 That Could Change Practice, Alter Companies, Move Stocks'

Jan 2, 2025 12:39PM TD Cowen on Trump Tariffs and Other Risks: 'Where Does Pharma Stand?'

Nov 22, 2024 12:22PM Moderna (MRNA) +9% as Jefferies says the market is nearing short term 'peak RFK negativity'

Nov 12, 2024 03:06AM Jefferies Downgrades GlaxoSmithKline (GSK:LN) (GSK) to Hold

Oct 31, 2024 03:09AM Guggenheim Downgrades GlaxoSmithKline (GSK:LN) (GSK) to Neutral

Oct 15, 2024 10:05AM GSK (GSK) Sues Moderna (MRNA) for US Patent Infringement Over MRNA Technology in Covid-19 Vaccines - Court Filing

Oct 9, 2024 12:56PM GSK (GSK) to Settle Zantac Product Liability Cases for up to $2.2B

Oct 9, 2024 12:47PM GSK (GSK) halted, news pending

Oct 8, 2024 07:02AM GSK (GSK) Presents Positive Data for AREXVY

Oct 7, 2024 07:07AM Pfizer (PFE) invalidates two GSK (GSK) RSV vaccine patents in U.K.

Oct 3, 2024 03:26AM GlaxoSmithKline (GSK:LN) (GSK) PT Lowered to GBP20 at Jefferies

Sep 18, 2024 07:00AM GSK (GSK) Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX

Sep 11, 2024 08:53AM TD Cowen Reiterates Hold Rating on GlaxoSmithKline (GSK:LN) (GSK)

Sep 6, 2024 07:16AM GSK (GSK) announces positive results from phase III trial of Nucala (mepolizumab) in COPD

Aug 28, 2024 06:00AM Deutsche Bank Reiterates Buy Rating on GlaxoSmithKline (GSK:LN) (GSK)

Aug 15, 2024 06:02AM Berenberg Reiterates Buy Rating on GlaxoSmithKline (GSK:LN) (GSK)

View More Recent Stories View Older Stories